Patient

WHY AJOVY

AJOVY can help reduce monthly migraine days

In clinical trials, when taken either monthly or quarterly over a 12-week period:

50% or more

About 41% of patients with chronic migraine (vs 18% on placebo) and 48% of patients with episodic migraine (vs 28% on placebo) had their monthly migraine days reduced by at least 50%

75% or more

About 21% of patients with chronic migraine (vs about 10% on placebo) and 27% of patients with episodic migraine (vs 15% on placebo) had their monthly migraine days reduced by at least 75%

100%

About 8% of patients with chronic migraine (vs 4% on placebo) and 10% of patients with episodic migraine (vs 5% on placebo) experienced no migraine days

Some patients saw results in
as early as 1 week

REAL-PATIENT STORIES

“Since taking AJOVY I’ve had fewer migraine days.”

Real-Patient Jill, video of their story with AJOVY

Jill

from Okemos, MI

Understanding possible side effects with AJOVY

The following side effects were reported by some patients included in AJOVY clinical trials and who were on either monthly or quarterly dosing:

    • AJOVY may cause allergic reactions, including itching, rash, and hives that can happen within hours and up to 1 month after receiving AJOVY.
    • Adverse reactions reported by ≥2% of patients on AJOVY and greater than placebo: some people reported mild to moderate injection-site reactions on AJOVY.
    • 2% or less of people discontinued AJOVY because of side effects.

Tell your healthcare provider if you have any side effect that bothers you or does not go away.

Now is the time to talk to your doctor
Resource icon

Additional AJOVY resources

See more
​